Skip to content

Price / earnings at other companies

IAR
Integra LifeSciencesIART
95.8×+70.8×
MiMedx Group logo
MiMedx GroupMDXG
19.1×-8.8×
Bioventus logo
BioventusBVS
21.6×
Artivion logo
ArtivionAORT
150×
LeMaitre Vascular logo
LeMaitre VascularLMAT
39.8×-2.1×
Vericel logo
VericelVCEL
76.3×-675×

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

Based on the most recent quarter.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s price / earnings?
Organogenesis Holdings Inc. (ORGO) reported price / earnings of 112.1× in Q1 2026.
What is the long-term trend for Organogenesis Holdings Inc.'s price / earnings?
Over 4 years (2020 to 2025), Organogenesis Holdings Inc.'s price / earnings has grown at a -24.5% compound annual growth rate (CAGR), from 54.7× to 17.8×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.